Merlin Medical symposium - Flow DiVeRter - current and future prospects

During the Merlin Medical symposium at LINNC Paris 2024, Dr. Alejandro Tomasello introduced the DiVeRt Flow Diverter system, a pioneering vascular reconstruction device. The DiVeRt implant is constructed from a Nitinol stent with a proprietary polymer coating, covering 60-80% of its length, and laser-drilled to provide approximately 50% surface coverage on the working length. The design includes radiopaque rings for easy length identification and a hydrophobic luminal surface, enhancing its biocompatibility. Compatible with Merlin’s 3Fr (MIND) microcatheter, the DiVeRt system has demonstrated high feasibility and effectiveness in preclinical studies, showing excellent vessel patency and complete aneurysm occlusion.

Dr. Alejandro Tomasello shared promising clinical results from the DiVeRt clinical study, involving 22 patients across two centers, with zero incidents of disabling stroke, major stroke, or neurological death within 12 months post-procedure. He highlighted various successful cases, including cavernous and Pcom aneurysms, emphasizing the device's ease of use and favorable outcomes. The device's future prospects are exciting, with potential innovations like customizable porosity membranes and drug-device combinations for enhanced therapeutic effects.

The DiVeRt Flow Diverter system represents a significant advancement in aneurysm treatment, offering great navigability, minimal metal content, and drug-binding capabilities.

Watch the full replay of Dr. Alejandro Tomasello's presentation to explore the potential of this innovative device further.

Sponsored by Merlin Medical